MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.730
-0.020 (-2.64%)
Oct 29, 2024, 4:00 PM EDT - Market closed
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $28.86 million as of October 29, 2024. Its market cap has decreased by -24.04% in one year.
Market Cap
28.86M
Enterprise Value
23.96M
1-Year Change
-24.04%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $28.86M, a decrease of -92.53%. That is a compound annual growth rate of -57.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 29.60M | -19.78% |
| Dec 29, 2023 | 36.90M | -58.16% |
| Dec 30, 2022 | 88.20M | -40.96% |
| Dec 31, 2021 | 149.40M | -61.33% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 30.63M |
| Neuronetics | 30.03M |
| FibroGen | 30.00M |
| Onconetix | 29.70M |
| Lipocine | 29.68M |
| Femasys | 29.57M |
| CytoMed Therapeutics | 29.54M |
| Curis | 29.42M |